Phase 3 THOR study: Results of erdafitinib (erda) versus chemotherapy (chemo) in patients (pts) with advanced or metastatic urothelial cancer (mUC) with select fibroblast growth factor receptor alterations (FGFRalt)
| dc.contributor.author | Loriot, Y | |
| dc.contributor.author | Matsubara, N | |
| dc.contributor.author | Park, SH | |
| dc.contributor.author | Huddart, RA | |
| dc.contributor.author | Burgess, EF | |
| dc.contributor.author | Houede, N | |
| dc.contributor.author | Banek, S | |
| dc.contributor.author | Laguerre, B | |
| dc.contributor.author | Guadalupi, V | |
| dc.contributor.author | Ku, JH | |
| dc.contributor.author | Triantos, S | |
| dc.contributor.author | Akapame, S | |
| dc.contributor.author | Deprince, K | |
| dc.contributor.author | Mukhopadhyay, S | |
| dc.contributor.author | Siefker-Radtke, AO | |
| dc.date.accessioned | 2023-09-11T12:20:32Z | |
| dc.date.available | 2023-09-11T12:20:32Z | |
| dc.date.issued | 2023-06-10 | |
| dc.identifier.citation | Journal of Clinical Oncology, 2023, 41 (17), | en_US |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/5961 | |
| dc.identifier.eissn | 1527-7755 | |
| dc.identifier.eissn | 1527-7755 | |
| dc.language.iso | eng | en_US |
| dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | en_US |
| dc.relation.ispartof | Journal of Clinical Oncology | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nd/4.0/ | en_US |
| dc.title | Phase 3 THOR study: Results of erdafitinib (erda) versus chemotherapy (chemo) in patients (pts) with advanced or metastatic urothelial cancer (mUC) with select fibroblast growth factor receptor alterations (FGFRalt) | en_US |
| dc.type | Conference Proceeding | |
| dcterms.dateAccepted | 2023-09-11 | |
| dc.date.updated | 2023-09-11T11:48:02Z | |
| rioxxterms.version | AM | en_US |
| rioxxterms.licenseref.startdate | 2023-06-10 | |
| rioxxterms.type | Conference Paper/Proceeding/Abstract | en_US |
| pubs.issue | 17 | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart) | |
| pubs.publication-status | Published | |
| pubs.volume | 41 | |
| icr.researchteam | Clinic Acad RT Huddart | en_US |
| dc.contributor.icrauthor | Huddart, Robert | |
| icr.provenance | Deposited by Mrs Rosalind Wright (impersonating Prof Robert Huddart) on 2023-09-11. Deposit type is initial. No. of files: 1. Files: Loriot_THOR_Cohort_1_NEJM_resubmission_proof_08SEP2023.pdf |
Files in this item
This item appears in the following collection(s)
Except where otherwise noted, this item's license is described
as
https://creativecommons.org/licenses/by-nd/4.0/